Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies
- 5 February 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 9 (3), 182-194
- https://doi.org/10.1038/nrc2561
Abstract
No abstract availableKeywords
This publication has 152 references indexed in Scilit:
- The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endotheliaMicrovascular Research, 2009
- The chemical biology of nitric oxide: Implications in cellular signalingFree Radical Biology & Medicine, 2008
- The effect of thrombospondin-1 on breast cancer metastasisBreast Cancer Research and Treatment, 2008
- Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cellsBiochemical Pharmacology, 2008
- Thrombospondins: from structure to therapeuticsCellular and Molecular Life Sciences, 2008
- Thrombospondins: from structure to therapeuticsCellular and Molecular Life Sciences, 2008
- Thrombospondins: from structure to therapeuticsCellular and Molecular Life Sciences, 2008
- CD36: Implications in cardiovascular diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Life history of eNOS: Partners and pathwaysCardiovascular Research, 2007
- AMP-activated protein kinase mediates VEGF-stimulated endothelial NO productionBiochemical and Biophysical Research Communications, 2007